Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
Goldberg, Aaron D., Atallah, Ehab, Rizzieri, David, Walter, Roland B., Chung, Ki-Young, Spira, Alexander, Stock, Wendy, Tallman, Martin S., Cruz, Hans G., Boni, Joseph, Havenith, Karin E.G., Chao, Grace, Feingold, Jay M., Wuerthner, Jens, Solh, Melhem
Published in Leukemia research (01.08.2020)
Published in Leukemia research (01.08.2020)
Get full text
Journal Article